Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 73,301Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5EUROAPI

02 61Sanofi

03 5Biocon

04 5Biosimilar Collaborations Ireland Limited

05 24Eli Lilly

06 1Farmak JSC

07 1Gan & Lee Pharmaceuticals

08 1Merck & Co

09 2ORIFARM GROUP AS

10 4Viatris

11 1Wanbang Biopharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Regulatory Info : Prescription

Registration Country : Denmark

Insulin Glargine

Brand Name : Lantus Optiset

Dosage Form : Injectable Solution

Dosage Strength : 100 U/ml

Packaging :

Approval Date : 06-02-2001

Application Number : 28103247201

Regulatory Info : Prescription

Registration Country : Denmark

EUROAPI Compnay Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

INSULIN GLARGINE RECOMBINANT

Brand Name : LANTUS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100 UNITS/ML

Packaging :

Approval Date :

Application Number : 21081

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Regulatory Info : Prescription

Registration Country : Denmark

Insulin Glargine

Brand Name : Lantus Solostar

Dosage Form : Solution For Injection

Dosage Strength : 100 U/ml

Packaging :

Approval Date : 01-09-2006

Application Number : 28104219807

Regulatory Info : Prescription

Registration Country : Denmark

EUROAPI Compnay Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Regulatory Info : Prescription

Registration Country : Denmark

Insulin Glargine

Brand Name : Lantus

Dosage Form : Injection Solution

Dosage Strength : 100 units/ml

Packaging :

Approval Date : 09-06-2000

Application Number : 28103089899

Regulatory Info : Prescription

Registration Country : Denmark

EUROAPI Compnay Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Regulatory Info : Prescription

Registration Country : Denmark

Insulin Glargine

Brand Name : Lantus

Dosage Form : Solution For Injection

Dosage Strength : 100 units/ml

Packaging :

Approval Date : 09-06-2000

Application Number : 28103065399

Regulatory Info : Prescription

Registration Country : Denmark

EUROAPI Compnay Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Regulatory Info : Prescription

Registration Country : Denmark

Insulin Glargine

Brand Name : Lantus Opticlik

Dosage Form : Solution For Injection

Dosage Strength : 100 units/ml

Packaging :

Approval Date : 31-08-2004

Application Number : 28103637404

Regulatory Info : Prescription

Registration Country : Denmark

EUROAPI Compnay Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

INSULIN GLARGINE RECOMBINANT

Brand Name : LANTUS SOLOSTAR

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300 UNITS/3ML (100 UNITS/ML)

Packaging :

Approval Date :

Application Number : 21081

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

INSULIN GLARGINE RECOMBINANT

Brand Name : TOUJEO SOLOSTAR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 450 UNITS/1.5ML (300 UNITS/ML)

Packaging :

Approval Date :

Application Number : 206538

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

INSULIN GLARGINE RECOMBINANT

Brand Name : TOUJEO MAX SOLOSTAR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 900 UNITS/3ML (300 UNITS/ML)

Packaging :

Approval Date :

Application Number : 206538

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

INSULIN GLARGINE; LIXISENATIDE

Brand Name : SOLIQUA 100/33

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML)

Packaging :

Approval Date :

Application Number : 208673

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Glargine

Brand Name : Lantus

Dosage Form : Insulin Glargine 1.000Iu 10Ml 1 Units Parenteral Use

Dosage Strength : 1 vial SC 1,000 IU 10 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

12

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Glargine

Brand Name : Lantus

Dosage Form : Insulin Glargine 100Iu/Ml 3Ml 5 Units Parenteral Use

Dosage Strength : 5 cartridges SC 100 IU/ml 3 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

13

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Italy

Glargine

Brand Name : Lantus

Dosage Form : Insulin Glargine 100Iu/Ml 3Ml 5 Units Parenteral Use

Dosage Strength : 5 pens SC 100 IU/ml 3 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

Sanofi Company Banner

14

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine

Brand Name : Lantus

Dosage Form : Injectable Solution In Cartridge

Dosage Strength : 3.6378mg/ml

Packaging :

Approval Date : 16/05/2002

Application Number : 55346

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

15

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine

Brand Name : Lantus SoloStar (Prefilled pen)

Dosage Form : Injectable Solution

Dosage Strength : 3.6378mg/ml

Packaging :

Approval Date : 06/07/2007

Application Number : 58044

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

16

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine

Brand Name : Toujeo SoloStar unitsml

Dosage Form : Injectable Solution In A Pre-Filled Pen

Dosage Strength :

Packaging :

Approval Date : 05/11/2015

Application Number : 65453

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

17

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Injectable Solution

Dosage Strength : 100mg;50mg

Packaging :

Approval Date : 05/10/2017

Application Number : 66283

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

18

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Injectable Solution

Dosage Strength : 100mg;33mg

Packaging :

Approval Date : 05/10/2017

Application Number : 66283

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

19

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Authorized

Registration Country : Spain

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Injectable Solution

Dosage Strength : 100UNIT; 33 MCG

Packaging :

Approval Date : 03-02-2017

Application Number : 1161157004

Regulatory Info : Authorized

Registration Country : Spain

Sanofi Company Banner

20

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Authorized

Registration Country : Spain

Insulin Glargine; Lixisenatide

Brand Name : Suliqua

Dosage Form : Injectable Solution

Dosage Strength : 100UNIT; 50MCG

Packaging :

Approval Date : 03-02-2017

Application Number : 1161157002

Regulatory Info : Authorized

Registration Country : Spain

Sanofi Company Banner